Be careful. Biotech stocks can be some of the most unstable companies to invest. One FDA rejection could send the stock price tumbling. Be very careful and do your own due dilligence.
I'm willing to lose around half before I pull out, and plan to follow the FDA approval statement very closely. It's scheduled for July 15.